Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÃøµÎÇϾǰüÀý¿¡¼­ÀÇ °ñ°üÀý¿° À¯µµ µ¿¹°¸ðµ¨ ºñ±³¿¬±¸

A Comparison Study on Animal Models for Osteoarthritis in Temporomandibular Joint

´ëÇѱ¸°­³»°úÇÐȸÁö 2011³â 36±Ç 4È£ p.261 ~ 271
À¯¼±³ç, ÀÌ¿µÃ¶, ¹ÚÇý·Ã, À¯¹ÌÇö, ÀüÇý¹Ì, ±è±¤¿¬, ±è»óÇå, ¿Á¼ö¹Î, °í¸í¿¬, ¾È¿ë¿ì, ¾È¼øö, Á¤¼ö¹Î,
¼Ò¼Ó »ó¼¼Á¤º¸
À¯¼±³ç ( Yu Sun-Nyoung ) - ºÎ»ê´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¹Ì»ý¹°ÇÐ ¹× ¸é¿ªÇб³½Ç
ÀÌ¿µÃ¶ ( Yi Young-Chul ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
¹ÚÇý·Ã ( Park Hae-Ryoun ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­º´¸®Çб³½Ç
À¯¹ÌÇö ( Ryu Mi-Heon ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­º´¸®Çб³½Ç
ÀüÇý¹Ì ( Jeon Hye-Mi ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
±è±¤¿¬ ( Kim Kwang-Youn ) - ºÎ»ê´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¹Ì»ý¹°ÇÐ ¹× ¸é¿ªÇб³½Ç
±è»óÇå ( Kim Sang-Hun ) - ºÎ»ê´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¹Ì»ý¹°ÇÐ ¹× ¸é¿ªÇб³½Ç
¿Á¼ö¹Î ( Ok Soo-Min ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
°í¸í¿¬ ( Ko Myung-Yun ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
¾È¿ë¿ì ( Ahn Yong-Woo ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç
¾È¼øö ( Ahn Soon-Cheol ) - ºÎ»ê´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¹Ì»ý¹°ÇÐ ¹× ¸é¿ªÇб³½Ç
Á¤¼ö¹Î ( Jeong Su-Min ) - ºÎ»ê´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø ±¸°­³»°úÇб³½Ç

Abstract

ÃøµÎÇϾǰüÀý¿¡¼­ ¹ß»ýÇÏ´Â °ñ°üÀý¿°Àº ÀúÀ۽à ÅëÁõ, °³±¸Á¦ÇÑ, °üÀýÀâÀ½, ±³ÇÕº¯È­¸¦ À¯¹ßÇÏ¿© ȯÀÚÀÇ »îÀÇ ÁúÀ» ÀúÇϽÃÅ°´Âµ¥ °ü¿©ÇÏ´Â ÁÖ¿äÇÑ ÁúȯÀÌ´Ù. °ñ°üÀý¿°ÀÇ ÁøÇà°úÁ¤°ú ±×¿¡ µû¸¥ Á¦¾î¹æ¹ýÀ» ¿¬±¸Çϱâ À§ÇÏ¿© ´Ù¾çÇÑ ¿¬±¸¹æ¹ýÀÌ ½ÃµµµÇ°í ÀÖ´Ù. ÀÌ Áß °ñÁ¶Á÷¸é¿¡¼­ÀÇ Á¶Á÷º¯È­, È°¸·¾×ÀÇ ¼ººÐº¯È­, È°¸·ÀÇ Á¶Á÷º¯È­, ÁÖº¯Á¶Á÷ÀÇ º¯È­, ÅëÁõ¿¡ ´ëÇÑ ¹ÝÀÀÀ» È®ÀÎÇÒ ¼ö ÀÖ´Â µ¿¹°¸ðµ¨ÀÌ ÁÖ·Î ¸¹ÀÌ ÀÌ¿ëµÈ´Ù. º» ¿¬±¸¿¡¼­´Â ½ÇÇ赿¹°¿¡¼­ ´Ù¾çÇÑ ¹æ¹ýÀ¸·Î ÃøµÎÇϾǰüÀý °ñ°üÀý¿°À» À¯µµÇÏ¿© ÇϾǰüÀýÇ¥¸é¿¡¼­ ÀϾ Á¶Á÷º¯È­¸¦ ºñ±³ °üÂûÇÏ¿´À¸¸ç °¢ µ¿¹°¸ðµ¨ÀÇ ¿¬±¸ È°¿ë¹æ¾È¿¡ ´ëÇÏ¿© Ž»öÇÏ¿´´Ù. ÃøµÎÇϾǰüÀýÀÇ °üÀý°­¿¡ monosodium iodoacetate (MIA) ¿Í interleukin-1¥á(IL-1¥á)¸¦ Á÷Á¢ ÁÖÀÔÇÏ¿© ¾à¹°·Î °üÀý¿°À» À¯µµÇÏ¿© °üÀýÁ¶Á÷¸éÀ» °üÂûÇÏ¿´´Ù. ¶ÇÇÑ ¿©¼ºÈ£¸£¸óÀÎ ¿¡½ºÆ®·Î°Õ¿¡ ÀÇÇÑ °ñº¯È­¸¦ È®ÀÎÇϱâ À§ÇÏ¿© ³­¼ÒÀýÁ¦¼ú·Î ÀÎÇÑ °ñ´Ù°øÁõ À¯¹ß¸ðµ¨¿¡¼­ÀÇ ÇϾǰüÀýÀ» °üÂûÇÏ¿´À¸¸ç, ³ëÈ­µÈ ¹é¼­ÀÇ °üÀý¸éÀ» È®ÀÎÇÔÀ¸·Î½á ³ëÈ­·Î ÀÎÇÑ °ñº¯È­¸¦ °üÂûÇÏ¿´´Ù. Safranin-O ¿°»ö¹ý°ú Masson¡¯s trichrome ¿°»ö¹ýÀ» ÀÌ¿ëÇÏ¿© °¢°¢ÀÇ °üÀý¸é¿¡¼­ ¼¼Æ÷¹è¿­ÀÇ º¯È­, Äݶó°ÕÀÇ º¯È­, °ñÁ¶Á÷ÀÇ º¯È­ ¹× Æı«¾ç»ó¿¡ ´ëÇÏ¿© È®ÀÎÇÏ¿´°í Safranin-OÀÇ ¾ç¼º¹ÝÀÀÀ» È®ÀÎÇÏ¿© proteoglycans (PGs)ÀÇ Á¶Á÷³» ºÐÆ÷¸¦ ÃßÀûÇÏ¿´´Ù.

Osteoarthritis in patients with temporomandibular disorders(TMDs) induces pain, limitation of mouth opening, occlusal problems, and most commonly affects their life quality. Control method and progressive process of osteoarthritis are being extensively researched. The researchers focus on histologic changes, synovial changes, muscular and ligamental changes and observed reaction to pain. Therefore most of them developed the animal model for osteoarthritis in TMD patients.
In this study, we applied several methods which induces osteoarthritis of temporomandibular joint(TMJ) in rats or mice. For locally induce osteoarthritis in TMJ, Monosodium iodoacetate(MIA) or interleukin-1¥á(IL-1¥á) were injected into TMJ joint space for 5 or 3 weeks. Other groups are chosen for osteoarthritis under systemic control including hormonal changes and aging.
To observe cellular change, increased collagen, degenerative bony destruction and distribution of proteoglycans (PGs), safranin-O staining and Masson¡¯s trichrome staining were used.

Å°¿öµå

°ñ°üÀý¿°; µ¿¹°½ÇÇè; ¾à¹°À¯µµ °üÀý¿°; ÃøµÎÇϾǰüÀý
Animal model; Drug-induced arthritis; Osteoarthritis; Temporomandibular joint

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI